Rappta: Evotec : and Rappta Therapeutics enter discovery and development partnership focused on oncology target

(marketscreener.com) Evotec and Rappta Therapeutics enter discovery and development partnership focused on oncology target EVOTEC TO SUPPORT RAPPTA IN DEVELOPING SMALL MOLECULES THAT REACTIVATE PP2A, A KEY TUMOR SUPPRESSOR THE COLLABORATION LEVERAGES EVOTEC'S ONCOLOGY...https://www.marketscreener.com/quote/stock/EVOTEC-SE-436047/news/Evotec-and-Rappta-Therapeutics-enter-discovery-and-development-partnership-focused-on-oncology-tar-31887524/?utm_medium=RSS&utm_content=20201129